Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Powles

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Bone Marrow Transplantation|March 21, 2000
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 yearsS Kulkarni, R Powles, J Treleaven, et al.
Nature|February 12, 1987
A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemiaL C Chan, K K Karhi, S I Rayter, et al.
Bone Marrow Transplantation|March 29, 2000
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-upS J Vaidya, A Atra, S Bahl, et al.
Bone Marrow Transplantation|March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemiaS Singhal, R Powles, P J Henslee-Downey, et al.
Lancet (London, England)|August 11, 2001
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective surveyN Salooja, R M Szydlo, G Socie, et al.
Bone Marrow Transplantation|May 16, 2003
Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remissionS Singhal, P J Henslee-Downey, R Powles, et al.
Leukemia|May 23, 2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemiaG Visani, D Milligan, F Leoni, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Bone Marrow Transplantation|July 3, 2003
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host diseaseS Kulkarni, R Powles, B Sirohi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Bone Marrow Transplantation|March 21, 2000
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 yearsS Kulkarni, R Powles, J Treleaven, et al.
Nature|February 12, 1987
A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemiaL C Chan, K K Karhi, S I Rayter, et al.
Bone Marrow Transplantation|March 29, 2000
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-upS J Vaidya, A Atra, S Bahl, et al.
Bone Marrow Transplantation|March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemiaS Singhal, R Powles, P J Henslee-Downey, et al.
Lancet (London, England)|August 11, 2001
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective surveyN Salooja, R M Szydlo, G Socie, et al.
Bone Marrow Transplantation|May 16, 2003
Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remissionS Singhal, P J Henslee-Downey, R Powles, et al.
Leukemia|May 23, 2001
Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemiaG Visani, D Milligan, F Leoni, et al.
Bone Marrow Transplantation|November 9, 2004
Stem cell transplantation from identical twins in patients with myelodysplastic syndromesN Kröger, R Brand, A van Biezen, et al.
Bone Marrow Transplantation|July 3, 2003
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host diseaseS Kulkarni, R Powles, B Sirohi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Pageof 20